UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 436

Sortiert nach

Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1

Nature medicine, 2009-08, Vol.15 (8), p.955-959

2009

Link zum Volltext

Verfügbarkeit prüfen

Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

Clinical infectious diseases, 2009-02, Vol.48 (3), p.350-361

2009

Link zum Volltext

Verfügbarkeit prüfen

Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

PLoS pathogens, 2016-01, Vol.12 (1), p.e1005381-e1005381

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1- Monoinfected Participants: A Phase II Clinical Trial

The Journal of infectious diseases, 2010-06, Vol.201 (11), p.1686-1696

2010

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment Levels of Soluble Cellular Receptors and Interleukin-6 Are Associated with HIV Disease Progression in Subjects Treated with Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2010-06, Vol.201 (12), p.1796-1805

2010

Link zum Volltext

Verfügbarkeit prüfen

Generation of an HIV-1-Resistant Immune System with CD34+ Hematopoietic Stem Cells Transduced with a Triple-Combination Anti-HIV Lentiviral Vector

Journal of Virology, 2012-05, Vol.86 (10), p.5719-5729

2012

Link zum Volltext

Verfügbarkeit prüfen

Increased Frequency of Regulatory T Cells Accompanies Increased Immune Activation in Rectal Mucosae of HIV-Positive Noncontrollers

Journal of Virology, 2011-11, Vol.85 (21), p.11422-11434

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of Long-Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1931-1942

2005

Link zum Volltext

Verfügbarkeit prüfen

HIV Controllers with HLA-DRB113 and HLA-DQB106 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses

Journal of Virology, 2010-11, Vol.84 (21), p.11020-11029

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

Journal of acquired immune deficiency syndromes (1999), 2004-10, Vol.37 (2), p.1253

2004

Link zum Volltext

Verfügbarkeit prüfen

Immunodominant HIV-Specific CD8+ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers

Journal of Virology, 2010-10, Vol.84 (19), p.10354-10365

2010

Link zum Volltext

Verfügbarkeit prüfen

Multifunctional Human Immunodeficiency Virus (HIV) Gag-Specific CD8+ T-Cell Responses in Rectal Mucosa and Peripheral Blood Mononuclear Cells during Chronic HIV Type 1 Infection

Journal of Virology, 2007-06, Vol.81 (11), p.5460-5471

2007

Link zum Volltext

Verfügbarkeit prüfen

Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status

PloS one, 2008-10, Vol.3 (10), p.e3577-e3577

2008

Link zum Volltext

Verfügbarkeit prüfen

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

PLoS pathogens, 2017-05, Vol.13 (5), p.e1006368-e1006368

2017

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)

The Journal of infectious diseases, 2006-12, Vol.194 (12), p.1672-1676

2006

Link zum Volltext

Verfügbarkeit prüfen

Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation

mSphere, 2018-11, Vol.3 (6)

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

PLoS pathogens, 2016-03, Vol.12 (3), p.e1005540-e1005540

2016

Link zum Volltext

Verfügbarkeit prüfen

Age-Related Immune Dysfunction in Health and in Human Immunodeficiency Virus (HIV) Disease: Association of Age and HIV Infection with Naive CD8+ Cell Depletion, Reduced Expression of CD28 on CD8+ Cells, and Reduced Thymic Volumes

The Journal of infectious diseases, 2003-06, Vol.187 (12), p.1924-1933

2003

Link zum Volltext

Verfügbarkeit prüfen

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

Journal of acquired immune deficiency syndromes (1999), 2010-09, Vol.55 (1), p.39

2010

Link zum Volltext

Verfügbarkeit prüfen

Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study

Pharmacogenetics and genomics, 2006-11, Vol.16 (11), p.837-845

2006

Link zum Volltext

Verfügbarkeit prüfen

A Cytomegalovirus Vaccine for Transplantation: Are We Closer?

The Journal of infectious diseases, 2008-06, Vol.197 (12), p.1631-1633

2008

Link zum Volltext

Verfügbarkeit prüfen

Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral-Naive HIV-Infected Subjects

The Journal of infectious diseases, 2009-08, Vol.200 (4), p.614-618

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 436

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(405)
Mit Volltextzugriff
(375)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(436)
Japanisch
(60)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1- Monoinfected Participants: A Phase II Clinical Trial

Pretreatment Levels of Soluble Cellular Receptors and Interleukin-6 Are Associated with HIV Disease Progression in Subjects Treated with Highly Active Antiretroviral Therapy

Generation of an HIV-1-Resistant Immune System with CD34+ Hematopoietic Stem Cells Transduced with a Triple-Combination Anti-HIV Lentiviral Vector

Increased Frequency of Regulatory T Cells Accompanies Increased Immune Activation in Rectal Mucosae of HIV-Positive Noncontrollers

Pharmacogenetics of Long-Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study

HIV Controllers with HLA-DRB113 and HLA-DQB106 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses

C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

Immunodominant HIV-Specific CD8+ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers

Multifunctional Human Immunodeficiency Virus (HIV) Gag-Specific CD8+ T-Cell Responses in Rectal Mucosa and Peripheral Blood Mononuclear Cells during Chronic HIV Type 1 Infection

Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)

Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

Age-Related Immune Dysfunction in Health and in Human Immunodeficiency Virus (HIV) Disease: Association of Age and HIV Infection with Naive CD8+ Cell Depletion, Reduced Expression of CD28 on CD8+ Cells, and Reduced Thymic Volumes

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study

A Cytomegalovirus Vaccine for Transplantation: Are We Closer?

Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral-Naive HIV-Infected Subjects

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial

Suchergebnisse filtern